Oxygenta Pharmaceutical Ltd. - Research Center
524636 OXYGENTAPH Group (XT) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Profit before tax | -13.87 | -11.37 | -0.49 | 3.14 | -9.93 |
| Net cashflow-operating activity | -13.05 | -1.63 | -1.68 | -1.62 | -6.58 |
| Net cash used in investing activity | -4.09 | -9.64 | -4.94 | -6.72 | -0.50 |
| Netcash used in fin. activity | 17.13 | 11.22 | 6.33 | 8.67 | 3.19 |
| Net inc/dec in cash and equivlnt | -0.01 | -0.05 | -0.29 | 0.33 | -3.89 |
| Cash and equivalnt begin of year | 0.11 | 0.16 | 0.45 | 0.12 | 0.02 |
| Cash and equivalnt end of year | 0.10 | 0.11 | 0.16 | 0.45 | -3.87 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis